Redeye revises its valuation and raises its fair value range to SEK 4-25 with Base at 12 following Clavister’s partnership with BAE and impressive deal funnel within the CSP vertical. Clavister’s strategic positioning and increased likelihood of gaining design wins offset, in our opinion, its somewhat weaker than expected performance in the quarter.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

© Modular Finance, source Nordic Press Releases